Literature DB >> 24829108

From stem cells to red blood cells: how far away from the clinical application?

XiaoYan Xie1, YanHua Li, XueTao Pei.   

Abstract

The generation of red blood cells (RBCs) from stem cells provides a solution for deficiencies in blood transfusion. Currently, primary hematopoietic stem cells, embryonic stem cells and induced pluripotent stem cells have shown the potential to produce fully mature RBCs. Here, we discuss the advantages, induction protocols, progress and possible clinical applications of stem cells in RBC production.

Entities:  

Mesh:

Year:  2014        PMID: 24829108     DOI: 10.1007/s11427-014-4667-5

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  2 in total

Review 1.  Malaria modeling: In vitro stem cells vs in vivo models.

Authors:  Florian Noulin
Journal:  World J Stem Cells       Date:  2016-03-26       Impact factor: 5.326

Review 2.  Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2020-06-04       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.